A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
Clinical trial NCT07557927 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07557927
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2028-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.